metformin has been researched along with Acidosis, Diabetic in 47 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin-associated lactic acidosis is a well-known metformin treatment complication; however, the development of euglycemic diabetic ketoacidosis (euDKA) has rarely been reported." | 8.31 | Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose. ( Fujimaru, T; Hifumi, T; Ito, Y; Kadota, N; Konishi, K; Kuno, H; Nagahama, M; Nakayama, M; Otani, N; Sekiguchi, M; Taki, F; Watanabe, K, 2023) |
| "The patient was diagnosed with eu-DKA accompanied by severe hypernatremia (corrected serum Na concentration, 163 mEq/L) and hypokalemia following dapagliflozin re-administration." | 7.96 | Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report. ( Ahn, DJ; Lee, IH, 2020) |
| "This was the first episode of diabetic ketoacidosis (DKA) for this patient." | 5.46 | Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. ( Andrews, TJ; Cox, RD; Kolb, J; Parker, C, 2017) |
| " Metformin and SGLT2 inhibitors should be discontinued in patients with severe forms of COVID-19 owing to the risks of lactic acidosis and ketoacidosis." | 5.05 | COVID-19 in diabetic patients: Related risks and specifics of management. ( Hermans, MP; Maiter, D; Orioli, L; Thissen, JP; Vandeleene, B; Yombi, JC, 2020) |
| "Metformin-associated lactic acidosis is a well-known metformin treatment complication; however, the development of euglycemic diabetic ketoacidosis (euDKA) has rarely been reported." | 4.31 | Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose. ( Fujimaru, T; Hifumi, T; Ito, Y; Kadota, N; Konishi, K; Kuno, H; Nagahama, M; Nakayama, M; Otani, N; Sekiguchi, M; Taki, F; Watanabe, K, 2023) |
| " The diagnosis leaned toward latent autoimmune diabetes in adults, and the therapeutic approach involved cessation of preprandial insulin therapy, regulation, and subsequent discontinuation of basal insulin and introduction of metformin." | 4.12 | Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report. ( Fousteris, E; Lygnos, D; Xenou, M; Zoupas, I, 2022) |
| "The patient was diagnosed with eu-DKA accompanied by severe hypernatremia (corrected serum Na concentration, 163 mEq/L) and hypokalemia following dapagliflozin re-administration." | 3.96 | Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report. ( Ahn, DJ; Lee, IH, 2020) |
| "Treatment with metformin is occasionally associated with the development of severe lactic acidosis." | 3.69 | Contraindications to metformin therapy in patients with NIDDM. ( Bosman, D; Krentz, AJ; Sulkin, TV, 1997) |
| "85 g metformin daily for 75 days, urinary retention caused by a prostatic adenoma induced functional renal insufficiency and hyperlactacidemia, rapidly reversed with treatment." | 3.66 | [Reversible lactic acidosis in a diabetic on high dose metformin (author's transl)]. ( Beaudot, C; Brohon, J; Lavieuville, M; Merceron, RE; Noël, M; Raymond, JP, 1980) |
| "The prevalence of type 2 diabetes mellitus (T2D) has risen in the United States and worldwide, with an increase in global prevalence from 4." | 2.61 | SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes. ( Donnan, K; Segar, L, 2019) |
| "Five of the patients had pre-existing type 2 diabetes mellitus (DM)." | 1.72 | COVID-19 and diabetic ketoacidosis: A case series at an urban district hospital in South Africa. ( Dicks, HN; Naidoo, K, 2022) |
| "To compare the incidence of diabetic ketoacidosis (DKA) among patients with type 2 diabetes mellitus (T2DM) who were new users of sodium glucose co-transporter 2 inhibitors (SGLT2i) versus other classes of antihyperglycemic agents (AHAs)." | 1.51 | Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases. ( Alba, M; Berlin, JA; DeFalco, F; Freedman, A; Hester, L; Lind, J; Meininger, G; Rosenthal, N; Ryan, PB; Schuemie, MJ; Sun, D; Voss, EA; Wang, L; Weaver, J; Yuan, Z, 2019) |
| "Severe hypertriglyceridemia was considered to have been a consequence of impaired insulin action and his apolipoprotein E4/2 phenotype." | 1.51 | Eruptive xanthomas in a patient with soft-drink diabetic ketosis and apolipoprotein E4/2. ( Aiba, S; Imai, J; Katagiri, H; Kikuchi, K; Kohata, M; Kurosawa, S; Nakajima, T; Satake, C; Sawada, S; Takahashi, K; Takeda, K; Tsuchiya, S, 2019) |
| "Diabetic ketoacidosis has been described as a rare complication of acromegaly and may be observed in 1% of affected patients." | 1.46 | Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly. ( Bilz, S; Brändle, M; Fournier, JY; Quarella, M; Walser, D, 2017) |
| "The insulin-induced edema is a rare complication of insulin therapy." | 1.46 | Insulin-induced edema: an unusual complication in a patient with diabetic ketosis. ( Chaker, F; Chihaoui, M; Rached, A; Slimane, H; Yazid, M, 2017) |
| "This was the first episode of diabetic ketoacidosis (DKA) for this patient." | 1.46 | Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. ( Andrews, TJ; Cox, RD; Kolb, J; Parker, C, 2017) |
| "Type 2 diabetes can present as diabetic ketoacidosis in obese adolescent subjects." | 1.32 | Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. ( Cox, J; Elkeles, RS; Elwig, C; Poulter, C; Valabhji, J; Watson, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (34.04) | 18.7374 |
| 1990's | 4 (8.51) | 18.2507 |
| 2000's | 4 (8.51) | 29.6817 |
| 2010's | 13 (27.66) | 24.3611 |
| 2020's | 10 (21.28) | 2.80 |
| Authors | Studies |
|---|---|
| Shamchuk, A | 1 |
| Doulla, M | 1 |
| Jetha, M | 1 |
| Xenou, M | 1 |
| Zoupas, I | 1 |
| Lygnos, D | 1 |
| Fousteris, E | 1 |
| Dicks, HN | 1 |
| Naidoo, K | 1 |
| Kuno, H | 1 |
| Fujimaru, T | 1 |
| Kadota, N | 1 |
| Konishi, K | 1 |
| Sekiguchi, M | 1 |
| Watanabe, K | 1 |
| Ito, Y | 1 |
| Nagahama, M | 1 |
| Taki, F | 1 |
| Hifumi, T | 1 |
| Otani, N | 1 |
| Nakayama, M | 1 |
| Wang, L | 1 |
| Voss, EA | 1 |
| Weaver, J | 1 |
| Hester, L | 1 |
| Yuan, Z | 1 |
| DeFalco, F | 1 |
| Schuemie, MJ | 1 |
| Ryan, PB | 1 |
| Sun, D | 1 |
| Freedman, A | 1 |
| Alba, M | 1 |
| Lind, J | 1 |
| Meininger, G | 1 |
| Berlin, JA | 1 |
| Rosenthal, N | 1 |
| Orioli, L | 1 |
| Hermans, MP | 1 |
| Thissen, JP | 1 |
| Maiter, D | 1 |
| Vandeleene, B | 1 |
| Yombi, JC | 1 |
| Lee, IH | 1 |
| Ahn, DJ | 1 |
| Koufakis, T | 1 |
| Metallidis, S | 1 |
| Zebekakis, P | 1 |
| Ajjan, RA | 1 |
| Kotsa, K | 1 |
| Pauchet, A | 1 |
| Schwotzer, N | 1 |
| Lamine, F | 1 |
| Perrottet, N | 1 |
| Zanchi, A | 1 |
| Golshayan, D | 1 |
| Wojtusciszyn, A | 1 |
| Chee, YJ | 1 |
| Tan, SK | 1 |
| Yeoh, E | 1 |
| Azapagasi, E | 1 |
| Yazici, MU | 1 |
| Korucu, A | 1 |
| Sarigul, B | 1 |
| Bozkurt, I | 1 |
| Tasar, M | 1 |
| Elmaogullari, S | 1 |
| Emeksiz, S | 1 |
| Öcgüder, DA | 1 |
| Quarella, M | 1 |
| Walser, D | 1 |
| Brändle, M | 1 |
| Fournier, JY | 1 |
| Bilz, S | 1 |
| Mesmar, B | 1 |
| Poola-Kella, S | 1 |
| Malek, R | 1 |
| Chaker, F | 1 |
| Yazid, M | 1 |
| Chihaoui, M | 1 |
| Rached, A | 1 |
| Slimane, H | 1 |
| Tsuchiya, S | 1 |
| Sawada, S | 1 |
| Takeda, K | 1 |
| Takahashi, K | 1 |
| Nakajima, T | 1 |
| Kohata, M | 1 |
| Kurosawa, S | 1 |
| Satake, C | 1 |
| Imai, J | 1 |
| Kikuchi, K | 1 |
| Aiba, S | 1 |
| Katagiri, H | 1 |
| Donnan, K | 1 |
| Segar, L | 1 |
| Krüger, HJ | 1 |
| De Wet, R | 1 |
| Blumberg, LH | 1 |
| Weyer, J | 1 |
| Lemke, FG | 1 |
| Mathuram Thiyagarajan, U | 1 |
| Ponnuswamy, A | 1 |
| Chung, A | 1 |
| Kuo, SF | 1 |
| Chuang, WY | 1 |
| Ng, S | 1 |
| Chen, CH | 1 |
| Chang, CN | 1 |
| Chou, CH | 1 |
| Weng, WC | 1 |
| Yeh, CH | 1 |
| Lin, JD | 1 |
| Rashid, O | 1 |
| Farooq, S | 1 |
| Kiran, Z | 1 |
| Islam, N | 1 |
| Valek, R | 1 |
| Von der Mark, J | 1 |
| Vellanki, P | 1 |
| Smiley, DD | 1 |
| Stefanovski, D | 1 |
| Anzola, I | 1 |
| Duan, W | 1 |
| Hudson, M | 1 |
| Peng, L | 1 |
| Pasquel, FJ | 1 |
| Umpierrez, GE | 1 |
| Andrews, TJ | 1 |
| Cox, RD | 1 |
| Parker, C | 1 |
| Kolb, J | 1 |
| Heine, RJ | 1 |
| Valabhji, J | 1 |
| Watson, M | 1 |
| Cox, J | 1 |
| Poulter, C | 1 |
| Elwig, C | 1 |
| Elkeles, RS | 1 |
| Bhasin, DK | 1 |
| Sidhu, RS | 1 |
| Bhansali, A | 1 |
| Nagi, B | 1 |
| Lunetta, M | 1 |
| Presti, C | 1 |
| Mughini, MT | 1 |
| Mughini, L | 1 |
| Beaudot, C | 1 |
| Merceron, RE | 1 |
| Lavieuville, M | 1 |
| Noël, M | 1 |
| Brohon, J | 1 |
| Raymond, JP | 1 |
| Pond, GD | 1 |
| Smyth, SH | 1 |
| Roach, DJ | 1 |
| Hunter, G | 1 |
| Pepper, GM | 1 |
| Schwartz, M | 1 |
| Sulkin, TV | 1 |
| Bosman, D | 1 |
| Krentz, AJ | 1 |
| Pinhas-Hamiel, O | 1 |
| Zeitler, P | 1 |
| Lalau, JD | 2 |
| Race, JM | 1 |
| Alexander, WD | 1 |
| Marples, J | 1 |
| Assan, R | 1 |
| Heuclin, C | 1 |
| Ganeval, D | 1 |
| Bismuth, C | 1 |
| George, J | 1 |
| Girard, JR | 1 |
| Clarke, BF | 2 |
| Campbell, IW | 1 |
| Mirouze, J | 1 |
| Mion, C | 1 |
| Beraud, JJ | 1 |
| Selam, JL | 1 |
| Andrejak, M | 1 |
| Morinière, P | 1 |
| Coevoet, B | 1 |
| Debussche, X | 1 |
| Westeel, PF | 1 |
| Fournier, A | 1 |
| Quichaud, J | 1 |
| Lambert, H | 1 |
| Isnard, F | 1 |
| Delorme, N | 1 |
| Claude, D | 1 |
| Bollaert, PE | 1 |
| Straczek, J | 1 |
| Larcan, A | 1 |
| Yang, DP | 1 |
| Liang, JZ | 1 |
| Luo, ZT | 1 |
| Lebacq, EG | 1 |
| Tirzmalis, A | 1 |
| Uvnäs, B | 1 |
| Hayat, JC | 1 |
| Duwoos, H | 1 |
| Bertrand, CM | 1 |
| Husson, A | 1 |
| Cramer, J | 1 |
| Tayot, J | 1 |
| Debry, G | 1 |
| Laurent, J | 1 |
| Walker, RS | 1 |
| Duncan, LJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ketosis-Prone Diabetes in African Americans: Predictive Markers, Underlying Mechanisms, and Treatment Outcomes: The Effects of Metformin vs. Sitagliptin on Beta-Cell Preservation in Obese Subjects With Ketosis-Prone Type 2 Diabetes Mellitus[NCT01099618] | Phase 4 | 48 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
For those patients that are able to discontinue insulin therapy at or <12 weeks, how long were they able to well controlled with an A1c <7% on the agent that they were randomized to. (NCT01099618)
Timeframe: 3 years
| Intervention | days (Median) |
|---|---|
| Metformin | 472 |
| Sitagliptin | 589 |
| Placebo | 111 |
8 reviews available for metformin and Acidosis, Diabetic
| Article | Year |
|---|---|
COVID-19 in diabetic patients: Related risks and specifics of management.
Topics: Acidosis, Lactic; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Critical Illness; | 2020 |
[Post-transplantation diabetes in kidney transplant: from the diabetologist point of view].
Topics: Diabetes Mellitus; Diabetic Ketoacidosis; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic A | 2020 |
Dissecting the interaction between COVID-19 and diabetes mellitus.
Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Blood Glucose; Chloroquine; Comorbidity; COVID- | 2020 |
THE PHYSIOLOGY BEHIND DIABETES MELLITUS IN PATIENTS WITH PHEOCHROMOCYTOMA: A REVIEW OF THE LITERATURE.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Blood Glucose; Catecholamines; Diabetes Mellitus; Diabetes Mel | 2017 |
SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes.
Topics: Acidosis, Lactic; Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Ketoacido | 2019 |
[Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
Topics: Aged; Ambulatory Care; Biguanides; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Combinations; Fema | 1980 |
Metformin and lactic acidosis in diabetic humans.
Topics: Acidosis, Lactic; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Humans; Hypoglycemic Agents; Met | 2000 |
Advances in the treatment of diabetes mellitus.
Topics: Blood Glucose; Chlorpropamide; Clofibrate; Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis; | 1971 |
1 trial available for metformin and Acidosis, Diabetic
| Article | Year |
|---|---|
Randomized Controlled Study of Metformin and Sitagliptin on Long-term Normoglycemia Remission in African American Patients With Hyperglycemic Crises.
Topics: Adolescent; Adult; Black or African American; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic K | 2016 |
38 other studies available for metformin and Acidosis, Diabetic
| Article | Year |
|---|---|
Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes.
Topics: Adolescent; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Humans; Hypoglycemic Ag | 2021 |
Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report.
Topics: Adult; Autoantibodies; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Hashimoto Disease; Humans; | 2022 |
COVID-19 and diabetic ketoacidosis: A case series at an urban district hospital in South Africa.
Topics: Adult; Biphasic Insulins; COVID-19; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Female; Glycat | 2022 |
Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.
Topics: Acidosis; Acidosis, Lactic; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Female; Humans; Ketone | 2023 |
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.
Topics: Administrative Claims, Healthcare; Aged; Blood Glucose; Databases, Factual; Diabetes Mellitus, Type | 2019 |
Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Benzhydryl Compounds; Blood Glucose; Diabe | 2020 |
Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?
Topics: Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Cytokines; Diabetes Mell | 2020 |
Severe Complication of Diabetic Ketoacidosis and Metformin Intoxication: Bilateral Leg Amputation.
Topics: Amputation, Surgical; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Humans; Leg; Metformin | 2021 |
Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly.
Topics: Adenoma; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, Combi | 2017 |
Insulin-induced edema: an unusual complication in a patient with diabetic ketosis.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Edema; Humans; Insulin; Male; Metformin | 2017 |
Eruptive xanthomas in a patient with soft-drink diabetic ketosis and apolipoprotein E4/2.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adolescent; Apolipoprotein E2; Apolipoprotein E4; Carbonated B | 2019 |
Atypical presentation of Crimean-Congo haemorrhagic fever: Lessons learned.
Topics: Acidosis; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Diagnosis, Differential; Dr | 2019 |
An enigmatic triad of acute pancreatitis, diabetic ketoacidosis and hypertriglyceridaemia: who is the culprit?
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Fluid Therapy; Humans; Hydroxymethylglutary | 2019 |
Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent.
Topics: Adenoma; Adolescent; Adolescent Development; Antineoplastic Agents, Hormonal; Combined Modality Ther | 2013 |
Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin.
Topics: Adult; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, Combina | 2016 |
[Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors].
Topics: Benzhydryl Compounds; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic | 2017 |
Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
Topics: Acetone; Antihypertensive Agents; Blood Glucose; Canagliflozin; Diabetes Complications; Diabetic Ket | 2017 |
[Does a reduced kidney function (creatinine clearance 10-15 ml/min), without acidosis, increase the risk for the rise of lactic acidosis caused by metformin?].
Topics: Acidosis, Lactic; Contraindications; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Diabetic Neph | 2002 |
Type 2 diabetes presenting as diabetic ketoacidosis in adolescence.
Topics: Acanthosis Nigricans; Adolescent; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; | 2003 |
Diabetic ketoacidosis in a patient with chronic calcific pancreatitis after minor papilla stent insertion.
Topics: Alcoholism; Calcinosis; Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; Diabetic K | 2004 |
[Reversible lactic acidosis in a diabetic on high dose metformin (author's transl)].
Topics: Adenoma; Diabetes Complications; Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Lactates; Male; M | 1980 |
Metformin and contrast media: genuine risk or witch hunt?
Topics: Contraindications; Contrast Media; Diabetes Mellitus; Diabetic Ketoacidosis; Diabetic Nephropathies; | 1996 |
Lactic acidosis associated with Glucophage use in a man with normal renal and hepatic function.
Topics: Acidosis, Lactic; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, Combination; Human | 1997 |
Contraindications to metformin therapy in patients with NIDDM.
Topics: Acidosis, Lactic; Alcoholism; Contraindications; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; D | 1997 |
Clinical problem-solving. The importance of a name.
Topics: Acanthosis Nigricans; Adolescent; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, T | 1999 |
Biguanides and lacticacidosis.
Topics: Diabetes Mellitus; Diabetic Ketoacidosis; Diet, Diabetic; Humans; Lactates; Metformin; Phenformin | 1977 |
Metformin-induced lactic acidosis in the presence of acute renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Alanine; Blood Glucose; Creatinine; Diabetic Ketoacidosis; Female; | 1977 |
Treatment of normal-weight diabetics.
Topics: Body Weight; Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Metformin | 1978 |
[Letter: Lactic acidosis during renal insufficiency in two diabetic patients treated with metformin].
Topics: Aged; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Humans; Kidney Failure, Chronic; Lactates; M | 1976 |
Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.
Topics: Acidosis, Lactic; Chromatography, Gas; Diabetic Ketoacidosis; Humans; Metformin; Renal Dialysis | 1989 |
[Physiopathological approach to pathological hyperlactatemia in the diabetic patient. Value of blood metformin].
Topics: Acidosis, Lactic; Adult; Aged; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Female; Humans; Lac | 1987 |
[Alteration of blood lactic acid levels in biguanide therapy in diabetics].
Topics: Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Humans; Lactates; Lacti | 1985 |
Metformin and lactic acidosis.
Topics: Acute Kidney Injury; Aged; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Humans; Lactates; Metfo | 1972 |
[Biguanides and lactic acid acidosis].
Topics: Adult; Diabetic Ketoacidosis; Humans; Lactates; Metformin; Middle Aged; Phenformin; Sweden | 1973 |
The treatment of lactic acidosis in the diabetic patient by peritoneal dialysis using sodium acetate. A report of two cases.
Topics: Acetates; Acute Kidney Injury; Aged; Bicarbonates; Blood Glucose; Carbon Dioxide; Chlorides; Diabeti | 1974 |
[Reversible hyperlactatemia induced by phenformin with muscular asthenia and cardio-respiratory signs].
Topics: Aged; Animals; Asthenia; Diabetes Complications; Diabetic Ketoacidosis; Dyspnea; Heart Diseases; Hep | 1970 |
[Lactic acidosis and sugar diabetics].
Topics: Alcoholism; Diabetic Ketoacidosis; Humans; Hypoxia; Lactates; Metformin; Phenformin; Starvation | 1970 |
Lactic acidosis through medicaments.
Topics: Acetates; Acidosis; Animals; Culture Techniques; Diabetes Mellitus; Diabetic Ketoacidosis; Female; G | 1970 |